Timber Hill’s Novartis NVS Stock Holding History

Timber Hill’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,833	Closed	-$712K	–	210
2018 Q1	$712K	Buy	+9,833	New	+$749K	0.11%	142
2017 Q2	–	Sell	-17,124	Closed	-$1.21M	–	1529
2017 Q1	$1.14M	Buy	17,124 +2,618	+18%	+$174K	0.01%	989
2016 Q4	$947K	Buy	14,506 +165	+1%	+$10.7K	﹤0.01%	1294
2016 Q3	$1.01M	Buy	+14,341	New	+$1.05M	﹤0.01%	1122
2016 Q2	–	Sell	-67,876	Closed	-$4.69M	–	2251
2016 Q1	$4.41M	Buy	67,876 +30,356	+81%	+$2.07M	0.02%	577
2015 Q4	$2.89M	Sell	37,520 -11,019	-23%	-$875K	0.01%	795
2015 Q3	$4M	Buy	+48,539	New	+$4.32M	0.02%	658
2015 Q2	–	Sell	-8,207	Closed	-$753K	–	2588
2015 Q1	$725K	Sell	8,207 -14,155	-63%	-$1.26M	﹤0.01%	1605
2014 Q4	$1.86M	Buy	+22,362	New	+$1.85M	0.01%	1068

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Timber Hill's NVS Position: Q2 2018 in Review

Timber Hill sold out of Novartis (NVS) in Q2 2018, closing a stake of 9,833 shares — an estimated $712K sold.

Timber Hill first reported a position in NVS in Q4 2014 and held it in 9 quarters. The position peaked at $4.41M in Q1 2016. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

Timber Hill reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 9,833 Novartis shares in Q2 2018, an estimated $712K.
Timber Hill first reported a position in Novartis in Q4 2014 and held it in 9 quarters.
Timber Hill's Novartis position peaked at $4.41M in Q1 2016.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.